Baker IDI Heart and Diabetes Institute, Melbourne, Australia (PJN, NS, NAM, GW, CKB, MTG, and PJM), and Metabolomics Australia, Bio21 Institute, The University of Melbourne, Melbourne, Australia (DPDS and DLT).
Am J Clin Nutr. 2014 Jan;99(1):46-53. doi: 10.3945/ajcn.113.071712. Epub 2013 Oct 23.
Reports have suggested that the consumption of dairy foods may reduce risk of type 2 diabetes on the basis of evidence of raised circulating ruminant fatty acids.
We determined whether certain phospholipid species and fatty acids that are associated with full-fat dairy consumption may also be linked to diminished insulin resistance.
Four variables of insulin resistance and sensitivity were defined from oral-glucose-tolerance tests in 86 overweight and obese subjects with metabolic syndrome. Plasma phospholipids, sphingolipids, and fatty acids were determined by using a lipidomic analysis and gas chromatography-mass spectrometry to provide objective markers of dairy consumption. Food records provided information on dairy products. Associations were determined by using linear regression analyses adjusted for potential confounders age, sex, systolic blood pressure, waist:hip ratio, or body mass index (BMI) and corrected for multiple comparisons.
Lysophosphatidylcholine, lyso-platelet-activating factor, and several phospholipid fatty acids correlated directly with the number of servings of full-fat dairy foods. Lysophosphatidylcholine and lyso-platelet-activating factor were also associated directly with insulin sensitivity when accounting for the waist:hip ratio (Matsuda index unadjusted, P < 0.001 for both; adjusted for multiple comparisons, P < 0.02 for both) and inversely with insulin resistance (fasting insulin unadjusted, P < 0.001 for both; adjusted, P = 0.04 and P < 0.05, respectively; homeostasis model assessment of insulin resistance adjusted, P = 0.04 for both; post-glucose insulin area under the plasma insulin curve during the 120 min of the test adjusted, P < 0.01 for both). The substitution of BMI for the waist:hip ratio attenuated associations modestly. Phospholipid fatty acid 17:0 also tended to be associated directly with insulin sensitivity and inversely with resistance.
Variables of insulin resistance were lower at higher concentrations of specific plasma phospholipids that were also indicators of full-fat dairy consumption. This trial was registered at clinicaltrials.gov as NCT00163943.
有报道称,由于循环反刍脂肪酸升高,食用乳制品可能降低 2 型糖尿病的风险。
我们旨在确定与全脂乳制品消费相关的某些磷脂种类和脂肪酸是否也与胰岛素抵抗降低有关。
在 86 名患有代谢综合征的超重和肥胖受试者中,我们通过口服葡萄糖耐量试验确定了 4 个胰岛素抵抗和敏感性变量。采用脂质组学分析和气相色谱-质谱法测定血浆磷脂、鞘脂和脂肪酸,为乳制品消费提供客观标志物。食物记录提供了乳制品信息。采用线性回归分析确定关联,调整潜在混杂因素(年龄、性别、收缩压、腰围/臀围比或体重指数(BMI)),并进行多重比较校正。
溶血磷脂酰胆碱、血小板激活因子溶血和几种磷脂脂肪酸与全脂乳制品的食用份数直接相关。在考虑腰围/臀围比时,溶血磷脂酰胆碱和血小板激活因子溶血也与胰岛素敏感性直接相关(Matsuda 指数未经校正,两者均 P < 0.001;校正多重比较后,两者均 P < 0.02),与胰岛素抵抗呈负相关(空腹胰岛素未经校正,两者均 P < 0.001;校正后,P = 0.04 和 P < 0.05;稳态模型评估的胰岛素抵抗校正后,两者均 P = 0.04;试验 120 分钟内血糖后胰岛素曲线下血浆胰岛素面积校正后,两者均 P < 0.01)。用腰围/臀围比代替 BMI 可适度减弱关联。磷脂脂肪酸 17:0 也倾向于与胰岛素敏感性直接相关,与抵抗性呈负相关。
特定血浆磷脂浓度较高时,胰岛素抵抗的变量较低,而这些磷脂浓度也是全脂乳制品消费的标志物。本试验在 clinicaltrials.gov 注册,编号为 NCT00163943。